New Pharmaxis Board Appointment: Richard van den Broek
7th
Apr 09
Release Date: 07/04/2009 12:00am
Pharmaceutical company Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced the appointment of the U.S. life science investment manager Richard van den Broek to its Board of Directors.
Categories: